71
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement

, , , , , & show all
Pages 2911-2919 | Published online: 19 Jun 2012

References

  • HaiboZJinzhongLYanLXuMLow-intensity international normalized ratio (INR) oral anticoagulant therapy in Chinese patients with mechanical heart valve prosthesesCell Biochem Biophys201262114715121892782
  • HammermeisterKSethiGKHendersonWGGroverFLOprianCRahimtoolaSHOutcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trialJ Am Coll Cardiol20003641152115811028464
  • FlorathIAlbertARosendahlUAlexanderTEnnkerICEnnkerJMid term outcome and quality of life after aortic valve replacement in elderly people: mechanical versus stentless biological valvesHeart20059181023102916020589
  • RhieSChoiJYJangISKimJWLeeCWParkHORelationship between the occurrence of thromboembolism and INR measurement interval in low intensity anticoagulation after aortic mechanical valve replacementKorean J Thorac Cardiovasc Surg6201144322022422263155
  • KaeberichAReindlIRaazUComparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro studyJ Thromb Thrombolysis201132441742521773837
  • EikelboomJWHirshJSpencerFABaglinTPWeitzJIAntiplatelet Drugs: Antithrombotic Therapy and Prevention of Thrombosis9th edAmerican College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141Suppl 2e89Se119S
  • PamukcuBHuberKLipGYAntiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agentsCurr Pharm Des201218685086022288444
  • LansbergMGO’DonnellMJKhatriPAntithrombotic and Thrombolytic Therapy for Ischemic Stroke: Antithrombotic Therapy and Prevention of Thrombosis9th edAmerican College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141Suppl 2e601Se636S
  • Paez EspinosaEVMuradJPKhasawnehFTAspirin: pharmacology and clinical applicationsThrombosis2012201217312422195279
  • WilsonAMBrittendenJBachooPFordINixonGFRandomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplastyJ Vasc Surg200950486186919786240
  • WangMYGaoCQWangYLiBJJiangSLRenCLAnalysis on the risk factors of intracardial thrombus after prosthetic valve replacement: a 1-year follow-up studyZhonghua Wai Ke Za Zhi201048752252520646663
  • MajidzadehAKKhalajVFatemehDCloning and expression of functional full-length human tissue plasminogen activator in Pichia pastorisAppl Biochem Biotechnol11201016272037204820455033
  • LudwigMWohnKDSchleuningWDOlekKAllelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion eventHum Genet19928843883921346771
  • KimPYTieuLDStaffordARFredenburghJCWeitzJIA high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activatorJ Biol Chem210201228774652466122187433
  • GandoSSawamuraAHayakawaMTrauma, shock, and disseminated intravascular coagulation: lessons from the classical literatureAnn Surg20112541101921368657
  • KunadianVGibsonCMRecombinant tissue-type plasminogen activators: “time matters”Drugs Today (Barc)201147755957022013562
  • ChenWHLinHSChenCIThe medicolegal issue of tissue plasminogen activator in ischemic stroke: a review of judiciary decrees in TaiwanActa Neurol Taiwan201120316317122009120
  • WuZJYangSFZhengSSShiDWuWWLiDWConstruction and biological activities of human tPA eukaryotic expression plasmidHepatobiliary Pancreat Dis Int20043451151515567735
  • EkhteraeDStanleyJCRetroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cellsJ Vasc Surg19952169539627776475
  • JiSJiJYangXWangXLingWZhangYExperimental study on construction of recombinant t-PA gene plasmid to prevent the thrombosis after mechanical valve replacementSouth China J Cardiovas Dis2006122132135
  • JiJZhangHWZhangZJLingWPTransfection of tissue-type plasminogen activator gene to prevent vascular anastomotic restenosis after coronary bypassChina Journal of Modern Medicine2007171416831686
  • ArnedoAIracheJMMerodioMEspuelas MillánMSAlbumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotideJ Control Release200494121722714684285
  • AyniéIVauthierCChacunHFattalECouvreurPSpongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotidesAntisense Nucleic Acid Drug Dev19999330131210435755
  • WangSBYuanFWuYNano-carriers for the target treatment of tumorJournal of Clinical Rehabilitative Tissue Eng Res2009132957395742
  • WangZXWangZGTreatment of ultrasound contrast agents for gene or drug deliveryChin J Interv Imaging200634304308
  • CasciaroSConversanoFRagusaAOptimal enhancement configuration of silica nanoparticles for ultrasound imaging and automatic detection at conventional diagnostic frequenciesInvest Radiol2010451171572420562708
  • PorterTRXieFTherapeutic ultrasound for gene deliveryEchocardiography200118434935311415508
  • ZhaoYZLuCTRecent advances in the applications of ultrasonic microbubbles as gene delivery systemsYao Xue Xue Bao200742212713117518038
  • LaoYXiuJCProgress of ultrasound microbubble contrast agent with gene and drug targeting therapyJ Med Imaging2007171213591361
  • ZhangYDGuoYLiuWDAlbumin nanoparticles used as gene carrierChin J Exp Surg2004211214561458
  • DuYFWanMXZhaoWMStudy on the preparation of a new sugar albumin microbubble ultrasound contrast agentYao Xue Xue Bao20013611859862
  • LiXinHeShengYunhuaGaoStudy for preparing specific targeted ultrasound contrast agentChinese J Ultrasound Med2007237493495
  • LingZYWangZRanHTExperiment study on ultrasound-mediated microbubble destruction deliver VEGF gene to ischemic myocardium of ratsChinese Ultrasound Med2002187502504
  • JiSJunJXiaohanYStudy on construction of nano tPA plasmid to prevent thrombosis after mechanical valve replacement in dogsJ Surg Res20111681e1e520605599
  • ArnedoAEspuelasSIracheJMAlbumin nanoparticles as carriers for a phosphodiester oligonucleotideInt J Pharm20022441–2597212204565
  • WangKMaGHPreparation and characterization of albumin nanospheres as drug carrierChinese J Pro Eng200442156159
  • LiuXBCaiMYPreparation and immunological characterization of mitoxantrone-loaded immuno-nanoparticles against human hepatomaChinese J Immuno200016526222652622269
  • FerraraKPollardRBordenMUltrasound microbubble contrast agents: fundamentals and application to gene and drug deliveryAnnu Rev Biomed Eng2007941544717651012
  • ChopraNDoddamreddyPGrewalHKumarPCAn elevated D-dimer value: a burden on our patients and hospitalsInt J Gen Med201258792 Epub January 25, 201222319245
  • UranoTSuzukiYParameters related to fibrinolysis and their meaningsRinsho Byori201159770370821874797